PYC Therapeutics Ltd
ASX:PYC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PYC Therapeutics Ltd
ASX:PYC
|
AU |
|
K
|
Kellogg Co
F:KEL
|
US |
|
E
|
EQT Corp
DUS:EQ6
|
US |
|
Trade Desk Inc
NASDAQ:TTD
|
US |
|
S
|
Syncom Formulations (India) Ltd
BSE:524470
|
IN |
|
Diamondrock Hospitality Co
NYSE:DRH
|
US |
|
M
|
Mazda Motor Corp
XMUN:MZA
|
JP |
|
H
|
Heidelberger Druckmaschinen AG
XHAM:HDD
|
DE |
|
H
|
Hugo Boss AG
XMUN:BOSS
|
DE |
|
Propel Holdings Inc
OTC:PRLPF
|
CA |
|
Aligos Therapeutics Inc
F:5WK
|
US |
|
H
|
Honda Motor Co Ltd
XHAM:HDM
|
JP |
|
5
|
51job Inc
F:IWQ
|
CN |
|
S
|
Schweizer Electronic AG
DUS:SCE
|
DE |
|
Paradigm Biopharmaceuticals Ltd
F:P86
|
AU |
|
K
|
Kindly MD Inc
NASDAQ:KDLY
|
US |
|
Deutsche Post AG
F:DPWA
|
DE |
|
Accel Entertainment Inc
NYSE:ACEL
|
US |
|
S
|
Seabridge Gold Inc
SWB:SRM
|
CA |
|
Eco Recycling Ltd
BSE:530643
|
IN |
|
Y
|
Yokohama Rubber Co Ltd
F:YRB
|
JP |
|
Snowflake Inc.
NYSE:SNOW
|
US |
Bankruptcy Probability
PYC Therapeutics Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
PYC Therapeutics Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
PYC Therapeutics Ltd
ASX:PYC
|
1.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
449.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
200.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
123.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
71.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
PYC Therapeutics Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, PYC Therapeutics Ltd has total debt of 436.9k AUD. This includes both short-term (0 AUD) and long-term (436.9k AUD) debt.
You can find a full breakdown on its Balance Sheet.
